ASOs are an effective treatment for disease-associated oligodendrocyte signatures in premanifest and symptomatic SCA3 mice
Article in Molecular Therapy (February 2024)
The most recent citing publications are shown below. View all 30 publications that cite this research output on Dimensions.
Article in Molecular Therapy (February 2024)
Article in Journal of Neurology (June 2023)
Book chapter (May 2023)